-
Analyst Opinions
NewTech Meets Beauty – Technological Innovations in the Beauty Industry – Industry Insights
Technological Innovations in the Beauty Industry Report Overview The integration of technology in the beauty space has steadily increased since the 19th century as technology empowers consumers with more effective solutions and allows brands to innovate. Technological innovations in the beauty industry have also given rise to consumer and brand-related benefits, chiefly about customization, convenience, accessibility, customer experience, and engagement. The ‘Tech Meets Beauty – Technological Innovations in the Beauty Industry’ insight report explores technological innovations in the beauty industry...
-
Analyst Opinions
Top Trends in Health and Beauty – Industry Insights
Top Trends in Health and Beauty Industry Report Overview Consumers continue to grapple with elevated costs, inhibiting the volume growth of the health and beauty industry. The cosmetics and toiletries industry has withstood significant challenges in recent years. As inflationary pressures are starting to ease globally, consumers are spending more but purchasing less in terms of volume. The consumer health industry is maintaining its momentum and value growth as the over-the-counter and vitamins and supplements categories continue to perform well....
-
Analyst Opinions
Beyond Filters – A Deep Dive into the Health and Beauty Choices of Generation Z and Generation Alpha
Health and Beauty Choices of Generation Z and Generation Alpha Report Overview Gen Z has been exposed to the COVID-19 pandemic and the cost-of-living crisis during their formative years. They have also experienced more ethnic diversity growing up, and considerably higher rates of education compared to their previous generations. Due to such factors, they are less loyal to brands compared to boomers and the Silent Generation. Around half of them intend to cut back on health and beauty products to...
-
Sector Analysis
NewFeminine Hygiene Market Opportunities, Trends, Growth Analysis and Forecast to 2028
Feminine Hygiene Market Report Overview The feminine hygiene market size was $37.5 billion. The market will grow at a CAGR of more than 4% during 2023-2028. Consumers, especially women, are becoming more conscious about the products they use. The potential long-term effects of exposing intimate areas to synthetic and potentially harmful chemicals are compelling them to seek safer alternatives. Additionally, modern consumers value transparency and are keen on understanding the ingredients in the products they use. Feminine Hygiene Market Outlook,...
-
Sector Analysis
Europe Health and Beauty Sector Overview, Market Size, Competitive Landscape and Forecast to 2027
Europe Health and Beauty Sector Overview The Europe health and beauty sector was valued at EUR 325.1 billion in 2022. The sector will grow at a CAGR of more than 4% from 2022 to 2027. The Europe health and beauty sector research report uses data from the retail database and showcases the trends in the market and sectors by value and volume It also reveals the brand leaders by market share in 2022 in each of the sectors as well...
-
Sector Analysis
NewSkincare Market Opportunities, Trends, Growth Analysis and Forecast to 2028
Skincare Market Report Overview The skincare market size was valued at $163.5 billion in 2023. Consumers’ increasing concerns about skin nourishment and rising preferences for a healthy skincare regime are strengthening the demand for skincare products, especially facial and body care solutions. These factors are expected to drive the skincare market growth at a CAGR of more than 2% from 2023 to 2028. Skincare Market Outlook 2023-2028 (USD Billion) Buy the Full Report for More Insights on the Skincare Market...
-
Product Insights
Beautiful Mine 1
The Beautiful Mine 1 is a coal mine in Brazil. It is currently in operation. Empower your strategies with our Beautiful Mine 1 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRGN-3006 in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRGN-3006 in Myelodysplastic Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRGN-3006 in Myelodysplastic Syndrome Drug Details: PRGN-3006 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRGN-3006 in Chronic Myelomonocytic Leukemia (CMML)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRGN-3006 in Chronic Myelomonocytic Leukemia (CMML) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRGN-3006 in Chronic Myelomonocytic Leukemia (CMML) Drug Details: PRGN-3006...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRGN-3006 in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRGN-3006 in Refractory Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRGN-3006 in Refractory Acute Myeloid Leukemia Drug Details: PRGN-3006...